RYMDX
Price
$139.21
Change
+$1.47 (+1.07%)
Updated
Dec 3 closing price
Net Assets
12.63M
UOPSX
Price
$100.87
Change
+$1.63 (+1.64%)
Updated
Dec 2 closing price
Net Assets
1.69B
Interact to see
Advertisement

RYMDX vs UOPSX

Header iconRYMDX vs UOPSX Comparison
Open Charts RYMDX vs UOPSXBanner chart's image
Rydex Mid-Cap 1.5x Strategy H
Price$139.21
Change+$1.47 (+1.07%)
VolumeN/A
Net Assets12.63M
ProFunds UltraNASDAQ-100 Svc
Price$100.87
Change+$1.63 (+1.64%)
VolumeN/A
Net Assets1.69B
RYMDX vs UOPSX Comparison Chart in %
View a ticker or compare two or three
VS
RYMDX vs. UOPSX commentary
Dec 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RYMDX is a Buy and UOPSX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
UOPSX has more cash in the bank: 1.69B vs. RYMDX (12.6M). RYMDX pays higher dividends than UOPSX: RYMDX (0.68) vs UOPSX (0.00). RYMDX was incepted earlier than UOPSX: RYMDX (24 years) vs UOPSX (28 years). UOPSX (2.53) is less costly to investors than RYMDX (1.79). RYMDX is a more actively managed with annual turnover of: 94.00 vs. UOPSX (22.00). RYMDX has a lower initial minimum investment than UOPSX: RYMDX (2500) vs UOPSX (15000). UOPSX annual gain was more profitable for investors over the last year : 24.05 vs. RYMDX (-6.29). UOPSX return over 5 years is better than : 60.43 vs. RYMDX (35.36).
RYMDXUOPSXRYMDX / UOPSX
Total Expense Ratio1.682.5366%
Annual Report Gross Expense Ratio1.792.5371%
Fund Existence24 years28 years-
Gain YTD4.79826.90018%
Front LoadN/AN/A-
Min. Initial Investment25001500017%
Min. Initial Investment IRAN/AN/A-
Net Assets12.6M1.69B1%
Annual Yield % from dividends0.680.00-
Returns for 1 year-6.2924.05-26%
Returns for 3 years31.99190.8117%
Returns for 5 years35.3660.4359%
Returns for 10 years127.41572.0422%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ENGGF16.20N/A
N/A
Enagas S.A.
ALPMF12.23N/A
N/A
Astellas Pharma, Inc.
AVNBF23.40N/A
N/A
AVON TECHNOLOGIES PLC
HOFBF0.17N/A
N/A
Hofseth Biocare ASA
FNTTF0.26N/A
N/A
XR IMMERSIVE TECH INC.